aztreonam has been researched along with Haemophilus influenzae Meningitis Type B in 9 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The monobactam aztreonam was used to treat 22 young patients with meningitis caused by gram-negative bacilli." | 7.67 | Aztreonam in the treatment of bacterial meningitis. ( Ayroza-Galvão, PA; Barbosa Júnior, SP; Cavalcante, NJ; Lorenco, R; Maassen, S; Martino, MD; Milstein-Kuschnaroff, TM; Mimica, IM; Mimica, LM, 1989) |
| "The penetration of aztreonam into cerebrospinal fluid was 7 to 15% and 9 to 25%, respectively, in experimental Haemophilus influenzae type b and Escherichia coli K1 meningitis." | 7.67 | Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1. ( McCracken, GH; Olsen, KD; Sakata, Y, 1985) |
| "Aztreonam (SQ 26,776), a new monocyclic beta-lactam agent, was compared with ampicillin, ampicillin plus chloramphenicol, and gentamicin in rabbits with experimental meningitis induced by, respectively, ampicillin-susceptible Haemophilus influenzae, ampicillin-resistant H." | 7.66 | Evaluation of aztreonam in experimental bacterial meningitis and cerebritis. ( Brodeur, JP; Foresman, P; Gratz, JC; Rodeheaver, G; Scheld, WM, 1983) |
| "The monobactam aztreonam was used to treat 22 young patients with meningitis caused by gram-negative bacilli." | 3.67 | Aztreonam in the treatment of bacterial meningitis. ( Ayroza-Galvão, PA; Barbosa Júnior, SP; Cavalcante, NJ; Lorenco, R; Maassen, S; Martino, MD; Milstein-Kuschnaroff, TM; Mimica, IM; Mimica, LM, 1989) |
| "The penetration of aztreonam into cerebrospinal fluid was 7 to 15% and 9 to 25%, respectively, in experimental Haemophilus influenzae type b and Escherichia coli K1 meningitis." | 3.67 | Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1. ( McCracken, GH; Olsen, KD; Sakata, Y, 1985) |
| "Aztreonam (SQ 26,776), a new monocyclic beta-lactam agent, was compared with ampicillin, ampicillin plus chloramphenicol, and gentamicin in rabbits with experimental meningitis induced by, respectively, ampicillin-susceptible Haemophilus influenzae, ampicillin-resistant H." | 3.66 | Evaluation of aztreonam in experimental bacterial meningitis and cerebritis. ( Brodeur, JP; Foresman, P; Gratz, JC; Rodeheaver, G; Scheld, WM, 1983) |
| "Aztreonam was administered intramuscularly in a dose of 50 mg/kg every 8 h." | 1.27 | Parenteral aztreonam in the treatment of Haemophilus influenzae type b meningitis in Egyptian children. ( Abu el Ella, AH; Dessouky, A; el Messidy, M; Farid, Z; Girgis, NI; Haberberger, RL; Woody, JN, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scheld, WM | 1 |
| Brodeur, JP | 1 |
| Gratz, JC | 1 |
| Foresman, P | 1 |
| Rodeheaver, G | 1 |
| McColm, AA | 1 |
| Ryan, DM | 1 |
| San Joaquin, VH | 1 |
| Stutman, HR | 1 |
| Marks, MI | 1 |
| Bonner, DP | 1 |
| Whitney, RR | 1 |
| Baughn, CO | 1 |
| Miller, BH | 1 |
| Olsen, SJ | 1 |
| Sykes, RB | 1 |
| Feris, J | 1 |
| Moledina, N | 1 |
| Rodriguez, WJ | 1 |
| Khan, WN | 1 |
| Puig, J | 1 |
| Wiedermann, BL | 1 |
| Ahmad, S | 1 |
| Ayroza-Galvão, PA | 1 |
| Milstein-Kuschnaroff, TM | 1 |
| Mimica, IM | 1 |
| Maassen, S | 1 |
| Barbosa Júnior, SP | 1 |
| Cavalcante, NJ | 1 |
| Lorenco, R | 1 |
| Mimica, LM | 1 |
| Martino, MD | 1 |
| Girgis, NI | 1 |
| Abu el Ella, AH | 1 |
| Farid, Z | 1 |
| Woody, JN | 1 |
| Haberberger, RL | 1 |
| el Messidy, M | 1 |
| Dessouky, A | 1 |
| Isani, Z | 1 |
| Rehman, N | 1 |
| Adil, N | 1 |
| el Messidi, M | 1 |
| McCracken, GH | 1 |
| Sakata, Y | 1 |
| Olsen, KD | 1 |
9 other studies available for aztreonam and Haemophilus influenzae Meningitis Type B
| Article | Year |
|---|---|
Evaluation of aztreonam in experimental bacterial meningitis and cerebritis.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Encephalitis; Escherichia coli Infections; Female; Gentam | 1983 |
Therapeutic activity of ceftazidime and eleven other beta-lactam antibiotics against experimental Haemophilus influenzae, type b meningitis.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Cephalosporins; Haemophilus influenzae; Meni | 1984 |
Hemophilus influenzae type b meningitis in infant rabbits. Pathogenesis and therapy.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Disease Models, Animal; Haemophilus Infections; Half-Life | 1984 |
In-vivo properties of SQ 26,776.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Enterobacteriaceae Infections; Haemophilus influenzae; La | 1981 |
Aztreonam in the treatment of gram-negative meningitis and other gram-negative infections.
Topics: Aztreonam; Bacterial Infections; Child; Child, Preschool; Female; Gastroenteritis; Gram-Negative Bac | 1989 |
Aztreonam in the treatment of bacterial meningitis.
Topics: Aztreonam; Bacterial Infections; Child, Preschool; Female; Humans; Infant; Male; Meningitis; Meningi | 1989 |
Parenteral aztreonam in the treatment of Haemophilus influenzae type b meningitis in Egyptian children.
Topics: Aztreonam; Female; Haemophilus influenzae; Humans; Infant; Injections, Intramuscular; Male; Meningit | 1988 |
Aztreonam in the treatment of gram-negative meningitis in children.
Topics: Anti-Bacterial Agents; Aztreonam; Child, Preschool; Escherichia coli Infections; Gram-Negative Bacte | 1987 |
Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Escherichia coli Infections; Male; Meningitis; Meningitis | 1985 |